Clinical Trial Update: Efficacy of Citicoline Eye Drops 2% on Visual Field Preservation in Patients With Open Angle Glaucoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy of 2% citicoline eye drops for preserving the visual field in open-angle glaucoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma Open-angle

Drugs mentioned

• Citicoline eye drops 2% (citicoline)

Snippet

Sponsor: Omikron Italia S.r.l. | Conditions: Glaucoma, Open-Angle | Phase 3 | Status: RECRUITING